Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The added value of contrast-enhanced spectral mammography for the assessment of symptomatic breast cancer patients

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.01.20
Views: 99
Rating:

Dr Rodrigo Alcantara - Hospital del Mar, Barcelona, Spain

Dr Rodrigo Alcantra speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the benefits of contrast-enhanced spectral mammography.

He explains the added value of using this technique for patients who are symptomatic, which allows the identification of multifocal lesions in the first assessment.

 

Related videos

follow us

SIOG metastatic renal cell carcinoma


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation